Medi Assist Healthcare Services Limited — ≥1% Shareholders
Every non-promoter shareholder owning 1% or more of Medi Assist Healthcare Services Limited, parsed from the latest quarterly Shareholding Pattern filing. Curated holders link to a tracked profile; mystery holders are flagged.
0 curated
21 mystery
Quarter: Mar 2026
| Holder | Type | % of company | Shares | Value (₹ Cr) |
|---|---|---|---|---|
| Hdfc Large And Mid Cap Fund | dii | 8.78% | 65,50,356 | — |
| ICICI Prudential Banking And Financial Services Fund | dii | 7.46% | 55,63,019 | — |
| Aditya Birla Sun Life Trustee Private Limited A/C - Aditya Birla Sun Life Elss Tax Saver Fund | dii | 7.06% | 52,64,748 | — |
| Goldman Sachs Funds - Goldman Sachs India Equity Portfolio | fii | 5.19% | 38,72,279 | — |
| Kotak Small Cap Fund | dii | 4.98% | 37,17,530 | — |
| Medimatter Health Management Private Limited | dii | 4.61% | 34,41,836 | — |
| Massachusetts Institute Of Technology | fii | 3.87% | 28,90,830 | — |
| Wasatch Emerging India Fund | fii | 3.54% | 26,37,452 | — |
| Aditya Birla Sun Life Insurance Company Limited | dii | 3.50% | 26,13,811 | — |
| Novo Holdings A/S | fii | 3.41% | 25,40,750 | — |
| Canara Robeco Mutual Fund A/C Canara Robeco Elss Tax Saver | dii | 2.86% | 21,37,519 | — |
| Sundaram Mutual Fund A/C Sundaram Services Fund | dii | 2.85% | 21,26,763 | — |
| Sbi Life Insurance Co. Ltd | dii | 2.83% | 21,14,502 | — |
| 360 One Special Opportunities Fund - Series 9 | dii | 2.73% | 20,39,224 | — |
| Eastspring Investments India Consumer Equity Open Limited | fii | 1.96% | 14,59,139 | — |
| Old Bridge Focused Fund | dii | 1.42% | 10,58,613 | — |
| Ntasain Discovery Master Fund | fii | 1.40% | 10,41,187 | — |
| Sbi General Insurance Company Limited | dii | 1.22% | 9,13,869 | — |
| 238 Plan Associates LLC | fii | 1.09% | 8,10,170 | — |
| Jupiter India Fund | fii | 1.05% | 7,87,071 | — |
| 360 One Special Opportunities Fund - Series 10 | dii | 1.01% | 7,55,517 | — |
Shareholding data sourced from NSE/BSE regulatory filings. Not investment advice. See our disclaimer and methodology.